LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics platforms for emerging markets, announced today that company representatives plan to attend MEDICA 2026 in Dusseldorf, Germany. MEDICA is one of the world’s largest international healthcare and medical technology trade fairs, and the company’s participation is intended to support its ongoing evaluation of healthcare technologies, strategic industry relationships, vendor solutions, digital infrastructure initiatives, and broader commercialization opportunities.
Management stated that attendance at the event will allow the company to engage with healthcare technology providers, telehealth vendors, pharmaceutical infrastructure participants, medical software developers, AI-focused healthcare companies, and other industry stakeholders operating throughout Europe, Latin America, and additional international markets. By participating in such international healthcare industry events, LataMed AI believes it can evaluate emerging technologies, support industry relationship development, and advance its long-term digital healthcare infrastructure strategy across Latin America and other developing markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., commented: “Healthcare systems around the world are rapidly moving toward technology-driven and AI-enabled infrastructure models. Our attendance at MEDICA reflects our commitment to engaging with industry participants, evaluating emerging technologies, and continuing to build a scalable healthcare platform designed to support long-term digital healthcare modernization initiatives throughout Latin America.”
The company remains in the development and commercialization stage with respect to certain aspects of its healthcare technology platform and business operations. LataMed AI cautions that attendance at industry conferences and trade fairs does not guarantee strategic relationships, commercial agreements, financing arrangements, technology integrations, revenue generation, or future operational success. The company continues to advance telehealth deployment initiatives, healthcare analytics integration, operational scalability planning, strategic relationship development, and broader commercialization efforts associated with its long-term digital healthcare ecosystem strategy throughout Latin America.
The announcement underscores LataMed AI’s strategic focus on positioning itself within the rapidly evolving healthcare technology landscape. By attending MEDICA, the company aims to identify potential partners and technologies that could accelerate its mission to build scalable telehealth and analytics solutions for emerging markets. The move is particularly significant given the increasing global adoption of digital health tools and AI-driven diagnostics, which are becoming critical components of modern healthcare delivery.
For more information about LataMed AI Corp., visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
